Literature DB >> 2122013

Risk factors for measles in a previously vaccinated population and cost-effectiveness of revaccination strategies.

E E Mast1, J L Berg, L P Hanrahan, J T Wassell, J P Davis.   

Abstract

Using data from a large measles outbreak that occurred in Dane County (Wisconsin) in 1986, we conducted a case-control study to evaluate risk factors for vaccine failure and assessed the cost-effectiveness of school-based revaccination strategies. Vaccination before a change in the measles vaccine stabilizer in 1979 (odds ratio, 5.5; 95% confidence interval, 1.05 to 28.9) and vaccination before age 15 months (odds ratio, 13.9; 95% confidence interval, 5.9 to 32.6) were identified as risk factors. Revaccination strategies for all students ($3444 per case prevented), students vaccinated before 1980 ($3166 per case prevented), and students vaccinated before age 15 months ($2546 per case prevented) were evaluated, assuming use of measles-mumps-rubella vaccine after the initial case was detected in a school. However, a large proportion of cases (43% to 53%) may not have been preventable using these strategies. Therefore, revaccination in all schools assessed to be at risk for measles may be necessary to prevent large outbreaks until a two-dose vaccination schedule is fully implemented.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122013

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  15 in total

1.  Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.

Authors:  M Paunio; H Peltola; M Valle; I Davidkin; M Virtanen; O P Heinonen
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

Review 2.  Routine childhood immunisation: is it worth it?

Authors:  S P Conway; B Leese
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

Review 3.  Pharmacoeconomics of immunisation: a review.

Authors:  R van den Oever; D de Graeve; B Hepp; A Stroobant; D Walckiers; V Van Casteren; F Van Loock; G Ducoffre; J Dewatripont; P Jacques
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

4.  The economics of screening for measles.

Authors:  J A Sellick
Journal:  Pharmacoeconomics       Date:  1992-12       Impact factor: 4.981

5.  Childhood immunisation in the new decade.

Authors: 
Journal:  BMJ       Date:  1991-04-20

6.  Economic evaluation of an extended acellular pertussis vaccine program for adolescents in Québec, Canada.

Authors:  Michael Iskedjian; John H Walker; Gaston De Serres; Thomas R Einarson
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

7.  Outbreak of measles in a highly vaccinated secondary school population.

Authors:  P A Sutcliffe; E Rea
Journal:  CMAJ       Date:  1996-11-15       Impact factor: 8.262

8.  Measles virus-specific antibody levels in individuals in Argentina who received a one-dose vaccine.

Authors:  Marcelo H Argüelles; Mariana L Orellana; Alejandro A Castello; Guillermo A Villegas; Matilde Masini; Alejandra L Belizan; Silvia González Ayala; Osmar D Vera; Graciela Glikmann
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

9.  Measles vaccine efficacy during an outbreak in a highly vaccinated population: incremental increase in protection with age at vaccination up to 18 months.

Authors:  G De Serres; N Boulianne; F Meyer; B J Ward
Journal:  Epidemiol Infect       Date:  1995-10       Impact factor: 2.451

10.  Revaccination of children during school-based measles outbreaks: potential impact of a new policy recommendation.

Authors:  J W Osterman; D Melnychuk
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.